期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 283, 期 45, 页码 31079-31086出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M806041200
关键词
-
资金
- National Institutes of Health [CA77935, CA107078]
- United States Department of Defense [DAMD 17-02-1-0671]
- Bankhead-Coley [07BB-01]
A search for regulators of estrogen receptor alpha(ER alpha) expression has yielded a set of microRNAs (miRNAs) for which expression is specifically elevated in ER alpha-negative breast cancer. Here we show distinct expression of a panel of miRNAs between ER alpha-positive and ER alpha-negative breast cancer cell lines and primary tumors. Of the elevated miRNAs in ER alpha-negative cells, miR-221 and miR-222 directly interact with the 3'-untranslated region of ER alpha. Ectopic expression of miR-221 and miR-222 in MCF-7 and T47D cells resulted in a decrease in expression of ER alpha protein but not mRNA, whereas knockdown of miR-221 and miR-222 partially restored ER alpha in ER alpha protein-negative/mRNA-positive cells. Notably, miR-221- and/or miR-222-transfected MCF-7 and T47D cells became resistant to tamoxifen compared with vector-treated cells. Furthermore, knockdown of miR-221 and/or miR-222 sensitized MDA-MB-468 cells to tamoxifen-induced cell growth arrest and apoptosis. These findings indicate that miR-221 and miR-222 play a significant role in the regulation of ER alpha expression at the protein level and could be potential targets for restoring ER alpha expression and responding to antiestrogen therapy in a subset of breast cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据